CA1052781A - Prostaglandin analog precursors - Google Patents
Prostaglandin analog precursorsInfo
- Publication number
- CA1052781A CA1052781A CA267,449A CA267449A CA1052781A CA 1052781 A CA1052781 A CA 1052781A CA 267449 A CA267449 A CA 267449A CA 1052781 A CA1052781 A CA 1052781A
- Authority
- CA
- Canada
- Prior art keywords
- dimethyl
- minutes
- indanyl
- phosphonate
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Abstract
ABSTRACT OF THE DISCLOSURE
Dialkyl oxophosponates of the formula:
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl).
2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; and n is an integer from 0 to 5; and a process for the preparation thereof; which compounds are useful as intermediates for preparing 15-substituted-.omega.-pentanor-prostaglandins.
Dialkyl oxophosponates of the formula:
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl).
2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; and n is an integer from 0 to 5; and a process for the preparation thereof; which compounds are useful as intermediates for preparing 15-substituted-.omega.-pentanor-prostaglandins.
Description
5'~
:
This is a divisiona]L of Application Serial No.185,366, filed on November 8, 1973, issued as P~t~nt No.
. 1~033,7~7 on June 27, 1978.
Thi3 inven~ion rela~es to novel dialkyl oxapho~-S phonatqg and the prepar~ion thëreof. The compou~d~ o~ his . invention are useful as xeagents in the preparation o~ the `. novel lS-sub6tituted-~-penta~orprostaglandins disclosed in ~he parent P~tent No. 1,033,727.
In accordance with the present invention there i~
provided a process for preparing a compound o~ the ~ormula: :
A-~CH2) -~-CH2-~ /
., CH3 ........... II
wherein A is cycloalkyl of from ~hree to ten carbon atoms, l-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl ox substituted 2-indanyl, wherein~the substituent is 1 15 halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an ,7, in~eger ~rom O to 5; which comp~ises reacting a Iower alkyl ~ ester of the formula: :
:: R
A-~CH2)n-~-O-lower alkyl ~ wherein A and n ar~ as defined above, with dimethyl methyl--l~ 2Q phosphonate.
~ Tha fQllowing Examples illustrate the i~vention .:~: and the manner in which it may be perfo~m~d. I~ these I
': Examples all temperatures are expressed in Centigrade, all , melting and boilin~ points are unc~rrected.
,~
~;
. .
.;
... . . . . ..... . : . , . .. , ~ . . . . .
~:, . :....... , . . , , . . ,.. ~.. . .,. . . ,: . , . . , ,~ .
,, ~ ~; . ,.,, .. ': ,., ~, .....
` -2~ ~5'~7~
~ EXAMPLE 1 . .
Dimethyl 2-oxo-2-(2-indanyl)ethylphosphonate A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran was cooled to -78 in a dry nitrogen atmosph~re. To the stirred phosphonate solu~ion was added 82.6 ml. of 2.25M _-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) ~ropwise over a period of 20 minu~es at such a rate that ~he reaction - temperature never rose above -65. After an additional 5 minutes sti~ring at -78, 14.0 g. (73.5 mmole) methyl indane-
:
This is a divisiona]L of Application Serial No.185,366, filed on November 8, 1973, issued as P~t~nt No.
. 1~033,7~7 on June 27, 1978.
Thi3 inven~ion rela~es to novel dialkyl oxapho~-S phonatqg and the prepar~ion thëreof. The compou~d~ o~ his . invention are useful as xeagents in the preparation o~ the `. novel lS-sub6tituted-~-penta~orprostaglandins disclosed in ~he parent P~tent No. 1,033,727.
In accordance with the present invention there i~
provided a process for preparing a compound o~ the ~ormula: :
A-~CH2) -~-CH2-~ /
., CH3 ........... II
wherein A is cycloalkyl of from ~hree to ten carbon atoms, l-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl ox substituted 2-indanyl, wherein~the substituent is 1 15 halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an ,7, in~eger ~rom O to 5; which comp~ises reacting a Iower alkyl ~ ester of the formula: :
:: R
A-~CH2)n-~-O-lower alkyl ~ wherein A and n ar~ as defined above, with dimethyl methyl--l~ 2Q phosphonate.
~ Tha fQllowing Examples illustrate the i~vention .:~: and the manner in which it may be perfo~m~d. I~ these I
': Examples all temperatures are expressed in Centigrade, all , melting and boilin~ points are unc~rrected.
,~
~;
. .
.;
... . . . . ..... . : . , . .. , ~ . . . . .
~:, . :....... , . . , , . . ,.. ~.. . .,. . . ,: . , . . , ,~ .
,, ~ ~; . ,.,, .. ': ,., ~, .....
` -2~ ~5'~7~
~ EXAMPLE 1 . .
Dimethyl 2-oxo-2-(2-indanyl)ethylphosphonate A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran was cooled to -78 in a dry nitrogen atmosph~re. To the stirred phosphonate solu~ion was added 82.6 ml. of 2.25M _-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) ~ropwise over a period of 20 minu~es at such a rate that ~he reaction - temperature never rose above -65. After an additional 5 minutes sti~ring at -78, 14.0 g. (73.5 mmole) methyl indane-
2-carboxylate was added dropwise at a rate that kept the re-action temperature less than -70 (20 minutes). After 1.0 hour at -73 the reaction mixture was allowed to warm to ambient ~emperature, neutralized with 20 ml. acetic acid and ro~ary evaporated to a white gel. The gelatinous material was taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portions o~ methylene chloride (4x), the combined organic extracts were backwashed (75 ml. H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue and distilled, b.p. 150-160 (0.1 mm) to give 17.0 g. (86.4%) : dimethyl 2-oxo-2-(2-indanyl)ekhylphosphonate.
The nmr spectrum (CDC13) of the distilled product exhibited a singlet at 7.15 ~ for the aromatic protons, a doublet at 3.76 ~ (J = 11 cps) for the OCH3, a singlet at '~ ~5 3.25 ~ for the ben7.ylic protons, a doublet at 3.18 ~ (J = 23 cps) for the PCH2, and a deformed triplet at 3.13 ~ (J = 2 cps) for the CHCO.
Additional Compound of the Formula . O, C~
(MeO)2~CH2~(cH2)n 30 A n b.p. nmr Data (p~m c)_(a) MeO ~ 0 240-243 (0.2 mm) 6.73(s), 3.84(s), 3.78(d), 3.22(d) G ~
1 ~1 160-162 (0.2 mm) 3.77(d), 3.06(d), 2.50(d) ,~ (a)distinct reso~ances.
'' , :
.
_3_ ~5~
; Additional Compound of the Formula (cont'd) : ~ n ~ nmr Data (E~m_~)(a) 1 209-212 (0.02 mm) 3.70(d), 2.93(d), 2.23(s) 2 195-200 (0.02 mm) 3.75(d), 3.08(d), 2.53(m) ~ <~
, 1 138-141 (0.3 mm) 3.78(d), 3.05~d) (a)distinct resonances.
~ X~MPLE 2 Dimeth~1 2-oxo-3-~2-indanyl)~ æ o~honate A ~olution of 20.4 gO ~164 mmoles) dimethyl methyl-: 10 phosphonate tAldrich) in 200 ml. dry tetrahydrofuran i9 cool-ed to -78 in a dry nitrogen atmosphere. ~o the ~tlrred phosphonate solution i~ added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at su~h a rate that he reaction lS temperature never rises above -65~ After an additional 5 minute~ ~tirring at -78t 14.0 g. ~73O5 mmole) methyl ~2-indanyl)acetate is added dropwise at a rate that keep~ the reaction temperature les~ than -70 ~20 minutes). After 1.0 hour at -78 the reaction mixture i~ allowad to warm to amb~ent temperatur~, ~eutralized w~th ao ml. ac~tic acid and rotary evaporat~d to a white gel. The galatlnou~ matar~al i8 takon up in 50 ml~ wate~, the aque~us pha~e extracted with 75 ml~ por~lonR o~ methylene chlorida ~4x), ~he com~ined organic ~xtract~ ara backwa~had (75 ml~ H2O), drlad tMgSO4), a~d aonc~nt~ated ~water a~pirator) to a arud~ r~ldue and di~illed, d:Lmethyl 2-oxo~3~ indanyl)propylpho~phona~e.
The produa~ o~ thi~ Example i~ u~e~ul a~ th~ start- -lng material for ~h~ ~ynthesis o~ 16-(2-indanyl)-~-tetranor-prostagland~n~ o~ the A, E, or F series via the proc~dur~s di~closed in Patent No. 1,033,727. Othex pre~ursor~ required ~or th~ ~ynth~ of 17 ~hrough 20 ~ub~tituted pro~taglandln ~, . , ~ ~ . .
. . - ,, . , . :
. : . ; : : , . . .. . . .
.' ~ . ' . . ' ' .:' . .
sf~
; 4-analogs disclosed in Patent No. 1,033,727 are prepared in the same way from the appropriate methyl esters.
.
Dimethyl 2-oxo-2-t2-(1,2,3,4-tetrahydrona~hthy~))phosphonate ; 5 A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen a~mosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwi~e over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. A~ter an additional 5 minutes stirring at -78, 14.0 g. (73.5 INmole) methyl 2-(1,2,3,4-tetrahydronaphthylcarboxylate) is added dropwise at a rate tha~ keeps the reaction temperature le s than 70 ; 15 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a whits gel. The gelatinous material is taken up in 50 ml. water, the aqueous ` phase extracted with 75 ml. portion~ of methylene chloride (4x), the combinad organic extracts are backwashed (75 ml.
- H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-(2-(1,2,3,4-tetrahydronaphthyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the synthesis of 15-(2-(1,2,3,4-tetrahydro-naphthyl))-~-tetranorprostaglandins of the A, E, or F series via ~he procedures disclosed in Patent No. 1,033,727. Other ~,; precursors required for the synthesis of 16 through 20 sub-stituted prostaglandin analogs disclosed in Patent NoO
1,033,727 are prepared in the same way from the appropriate ;- methyl esters.
EX~MPLE 4 Dimethyl 2-oxo-2-(2-~R-1,2,3,4-tetrahydronaphthyl))ethyl-hosnhonate `~ 35 A solution of 20~4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitro~en atmosphere. To the stirred ;; : .
. ~ . . .
~S'~71~
.5 phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at~ such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(R-1,2,3,4-tetrahydronaphthylcarboxylate) is added drop~ise at a rate that keeps the reaction temperature less than -70 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material is taken up in 50 ml. waker, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combined organic extracts are backwashed (75 ml.
H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue which is purified by column chroma~ography to give dime~hyl 2-oxo-2-~2-(R-1,2,3,4-tetrahydronaphthyl)3-ethylphosphonate.
The product o~ this Example is useful a~ the start-ing material for the synthesis of 15-(2-(R-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, E, or F
series via the procedures disclosed in Pa~ent No. 1,033,727.
Other precursors required for the synthesis of L6 through 20 substituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.
E~AMPLE 5 Dimethyl 2-oxo-2-(2-(S-1,2,3,4-tetrahydronaphthyl))ethyl-~hos~honate . ~ . . ~ .
A solution o~ 20.4 y. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M _-butyllithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a perlod of 20 minutes at suoh a rate that the rQaction temper-ature never rises above -Ç5. After an additional 5 minutes ` stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(S-1,2,3,4-~ tetrahydronaphthyl) is added dropwise at a rate that keeps ,. .
. :
.,,~
:.~ . ~ . , . . , . , ,. . : . ~
~::., ' , . . . , :
'','' ~ ` ' ' ' ' ' ;
:.: . . .
.
5'~7~
the reaction temperature less than -70~ (20 minutes). After 1.0 hour at -78 the reaction mix~ure is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combine~ organic extracts are backwashed (75 ml. H2O), dried (MgSO4), and con-;; centrated (water aspirator) to a crude residue which is i purified by column chromatography to give dimethyl 2-oxo-2-` 10 (2-(S-1,2,3,4-tetrahydronaph~hyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the syn~hesis of 15-(2-(S-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, ~ or F
series vla the procedures disclosed in Pat~nt No. 1,033,727.
Other precursors required for the synthesis of 16 through ~0 ~ubstituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.
; 20 Dimethyl 2-oxo-7-cyclopentylhept~lphosphonate A solution of 20.4 g (164 mmoles) dimethyl methyl~
phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cooled to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwiseover a period of 20 minutes at such a rate that the reaction ; temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. (73.5 mmole) methyl 6-cyclo-pentylhexanoate is added dropwise at a rate that keeps the 30 reaction temperature less than -70 (20 minutes~. After 1.0 hour at -78 the reaction mixture i9 allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portion~ of methylene chloride (4x), the combined organia extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-centrated ~water aspirator) to a crude residue and di~tilled , '"
:~"" . ', . .: ' ' ' . '."' ' ' ~ . . . . . ..
,: , . . .
,'.'.'"' , ,; . ,'' ,. , .'. ,',", "'. . ', ~: , ,, ' _7~ 7~
to give dimethyl-2--oxo-7-cyclopentylheptylphosphona~e.
The product of this Example is useful as the start-ing material for the synthesis of 20-cyclopentyl-~Ltetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursors required , for the synthesis of 15 through 19 substituted prostaglandin analogs disclosed in Patent No. 1,033,727 are pxepared in the same way from the appropriate methyl esters.
Dimethyl 2-oxo-2-c~clodecy~eth~lphosphonate A solution of 20.4 g. (164 mmole~) dimethyl methyl-phosphonate ~Aldrich) in 200 ml. dry tetrahydro~uran is cool-ed to -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. ~73.5 mmole) methyl cyclo-decane~arboxylate is added dropwise at a rate thak kept the r~action temperature leqs than -70 (20 minutes). After 1.0 , hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 mlO acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous pha~e extracted with 75 ml. portions of methylene chloride (4x), the combined organic , extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-`' centrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-cyclodecylethylpho~phonate.
The product of this Example is useful as the start-ing ma~erial for the synthesis of 15-cyclodecyl~-tetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursorq required for the synthe~is o~ 16 through 20 substikuted proskaglandin analogs disclosed in Patent No. 1,033,727 are prepared in the same way ~rom the appropriate methyl esters.
, , ~ . , .. ~ ,.
... . .
.
. . , : :
." ' ' ' ' :: ~ , s ~ . .
EX~MPLE 8 : Dimethyl 2-oxo-6-cyclopropylhexylpho~e_onate A solution o~ 20.4 g. (164 mmoles) dimethyl methyl-pho~phonate (~ldrich) in 200 ml. dry tetrahydro~uran is cool-S ed ~o -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexan~ solution (Al~a Inorganics, Inc.) dropwiae over a period of 20 minute~ at such a rate that tha reaction ; tempera~ure never rises above -65. After an addltional 5 minu~es stirring at -78, 11.5 g. ~73.5 mmol~) methyl 5-cyclopropylvalerate i~ added dropwise at a rate that keep~
the react~on t~mperature le~s than -70~ (20 minutes)~ After 1.0 hour at -78 the reaction mixture i~ allowed to wa~m to a~bient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material i8 taken up in 50 ml. water, the a~ueous phase extract~d with 75 ml. portion3 of methylene chlorid~ ~4x), thc combined organic extracts are backwashed (75 ml. H~O), dried ~MgSO4), and concentrated (water aspirator) to a crude re~ldue and distill~d to give dimethyl 2 oxo-6-cyclopropylhexylpho~phonate.
The product o~ this Example is uR~ful as the start-ing material for the synthesis of l9-cyclopropyl-~-tetranor-prostaglandins of the A, E or F erie~ via the procedures disclo~ed in Paten~ No. 1,033,727. Other precuxsor~ required for the synthesi3 o~ 15 thrsugh 18 and 20 ~ub3titute~ prosta-i glandin analogs disclo~ed in Patent Mo. 1,033,727 axa prepared in the same way from the appropriata methyl e~tex~.
.... :
~. 1 .~ .
;. ~ .
. . .
, . . . . , . , ... : ..
, . . . .
The nmr spectrum (CDC13) of the distilled product exhibited a singlet at 7.15 ~ for the aromatic protons, a doublet at 3.76 ~ (J = 11 cps) for the OCH3, a singlet at '~ ~5 3.25 ~ for the ben7.ylic protons, a doublet at 3.18 ~ (J = 23 cps) for the PCH2, and a deformed triplet at 3.13 ~ (J = 2 cps) for the CHCO.
Additional Compound of the Formula . O, C~
(MeO)2~CH2~(cH2)n 30 A n b.p. nmr Data (p~m c)_(a) MeO ~ 0 240-243 (0.2 mm) 6.73(s), 3.84(s), 3.78(d), 3.22(d) G ~
1 ~1 160-162 (0.2 mm) 3.77(d), 3.06(d), 2.50(d) ,~ (a)distinct reso~ances.
'' , :
.
_3_ ~5~
; Additional Compound of the Formula (cont'd) : ~ n ~ nmr Data (E~m_~)(a) 1 209-212 (0.02 mm) 3.70(d), 2.93(d), 2.23(s) 2 195-200 (0.02 mm) 3.75(d), 3.08(d), 2.53(m) ~ <~
, 1 138-141 (0.3 mm) 3.78(d), 3.05~d) (a)distinct resonances.
~ X~MPLE 2 Dimeth~1 2-oxo-3-~2-indanyl)~ æ o~honate A ~olution of 20.4 gO ~164 mmoles) dimethyl methyl-: 10 phosphonate tAldrich) in 200 ml. dry tetrahydrofuran i9 cool-ed to -78 in a dry nitrogen atmosphere. ~o the ~tlrred phosphonate solution i~ added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at su~h a rate that he reaction lS temperature never rises above -65~ After an additional 5 minute~ ~tirring at -78t 14.0 g. ~73O5 mmole) methyl ~2-indanyl)acetate is added dropwise at a rate that keep~ the reaction temperature les~ than -70 ~20 minutes). After 1.0 hour at -78 the reaction mixture i~ allowad to warm to amb~ent temperatur~, ~eutralized w~th ao ml. ac~tic acid and rotary evaporat~d to a white gel. The galatlnou~ matar~al i8 takon up in 50 ml~ wate~, the aque~us pha~e extracted with 75 ml~ por~lonR o~ methylene chlorida ~4x), ~he com~ined organic ~xtract~ ara backwa~had (75 ml~ H2O), drlad tMgSO4), a~d aonc~nt~ated ~water a~pirator) to a arud~ r~ldue and di~illed, d:Lmethyl 2-oxo~3~ indanyl)propylpho~phona~e.
The produa~ o~ thi~ Example i~ u~e~ul a~ th~ start- -lng material for ~h~ ~ynthesis o~ 16-(2-indanyl)-~-tetranor-prostagland~n~ o~ the A, E, or F series via the proc~dur~s di~closed in Patent No. 1,033,727. Othex pre~ursor~ required ~or th~ ~ynth~ of 17 ~hrough 20 ~ub~tituted pro~taglandln ~, . , ~ ~ . .
. . - ,, . , . :
. : . ; : : , . . .. . . .
.' ~ . ' . . ' ' .:' . .
sf~
; 4-analogs disclosed in Patent No. 1,033,727 are prepared in the same way from the appropriate methyl esters.
.
Dimethyl 2-oxo-2-t2-(1,2,3,4-tetrahydrona~hthy~))phosphonate ; 5 A solution of 20.4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen a~mosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwi~e over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. A~ter an additional 5 minutes stirring at -78, 14.0 g. (73.5 INmole) methyl 2-(1,2,3,4-tetrahydronaphthylcarboxylate) is added dropwise at a rate tha~ keeps the reaction temperature le s than 70 ; 15 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a whits gel. The gelatinous material is taken up in 50 ml. water, the aqueous ` phase extracted with 75 ml. portion~ of methylene chloride (4x), the combinad organic extracts are backwashed (75 ml.
- H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-(2-(1,2,3,4-tetrahydronaphthyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the synthesis of 15-(2-(1,2,3,4-tetrahydro-naphthyl))-~-tetranorprostaglandins of the A, E, or F series via ~he procedures disclosed in Patent No. 1,033,727. Other ~,; precursors required for the synthesis of 16 through 20 sub-stituted prostaglandin analogs disclosed in Patent NoO
1,033,727 are prepared in the same way from the appropriate ;- methyl esters.
EX~MPLE 4 Dimethyl 2-oxo-2-(2-~R-1,2,3,4-tetrahydronaphthyl))ethyl-hosnhonate `~ 35 A solution of 20~4 g. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitro~en atmosphere. To the stirred ;; : .
. ~ . . .
~S'~71~
.5 phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at~ such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(R-1,2,3,4-tetrahydronaphthylcarboxylate) is added drop~ise at a rate that keeps the reaction temperature less than -70 (20 minutes). After 1.0 hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material is taken up in 50 ml. waker, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combined organic extracts are backwashed (75 ml.
H2O), dried (MgSO4), and concentrated (water aspirator) to a crude residue which is purified by column chroma~ography to give dime~hyl 2-oxo-2-~2-(R-1,2,3,4-tetrahydronaphthyl)3-ethylphosphonate.
The product o~ this Example is useful a~ the start-ing material for the synthesis of 15-(2-(R-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, E, or F
series via the procedures disclosed in Pa~ent No. 1,033,727.
Other precursors required for the synthesis of L6 through 20 substituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.
E~AMPLE 5 Dimethyl 2-oxo-2-(2-(S-1,2,3,4-tetrahydronaphthyl))ethyl-~hos~honate . ~ . . ~ .
A solution o~ 20.4 y. (164 mmoles) dimethyl methyl-phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cool-ed to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M _-butyllithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a perlod of 20 minutes at suoh a rate that the rQaction temper-ature never rises above -Ç5. After an additional 5 minutes ` stirring at -78, 14.0 g. (73.5 mmole) methyl 2-(S-1,2,3,4-~ tetrahydronaphthyl) is added dropwise at a rate that keeps ,. .
. :
.,,~
:.~ . ~ . , . . , . , ,. . : . ~
~::., ' , . . . , :
'','' ~ ` ' ' ' ' ' ;
:.: . . .
.
5'~7~
the reaction temperature less than -70~ (20 minutes). After 1.0 hour at -78 the reaction mix~ure is allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portions of methylene chloride (4x), the combine~ organic extracts are backwashed (75 ml. H2O), dried (MgSO4), and con-;; centrated (water aspirator) to a crude residue which is i purified by column chromatography to give dimethyl 2-oxo-2-` 10 (2-(S-1,2,3,4-tetrahydronaph~hyl))ethylphosphonate.
The product of this Example is useful as the start-ing material for the syn~hesis of 15-(2-(S-1,2,3,4-tetra-hydronaphthyl))-~-tetranorprostaglandins of the A, ~ or F
series vla the procedures disclosed in Pat~nt No. 1,033,727.
Other precursors required for the synthesis of 16 through ~0 ~ubstituted prostaglandin analogs disclosed in Patent No.
1,033,727 are prepared in the same way from the appropriate methyl esters.
; 20 Dimethyl 2-oxo-7-cyclopentylhept~lphosphonate A solution of 20.4 g (164 mmoles) dimethyl methyl~
phosphonate (Aldrich) in 200 ml. dry tetrahydrofuran is cooled to -78 in a dry nitrogen atmosphere. ~o the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwiseover a period of 20 minutes at such a rate that the reaction ; temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. (73.5 mmole) methyl 6-cyclo-pentylhexanoate is added dropwise at a rate that keeps the 30 reaction temperature less than -70 (20 minutes~. After 1.0 hour at -78 the reaction mixture i9 allowed to warm to ambient temperature, neutralized with 20 ml. acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous phase extracted with 75 ml. portion~ of methylene chloride (4x), the combined organia extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-centrated ~water aspirator) to a crude residue and di~tilled , '"
:~"" . ', . .: ' ' ' . '."' ' ' ~ . . . . . ..
,: , . . .
,'.'.'"' , ,; . ,'' ,. , .'. ,',", "'. . ', ~: , ,, ' _7~ 7~
to give dimethyl-2--oxo-7-cyclopentylheptylphosphona~e.
The product of this Example is useful as the start-ing material for the synthesis of 20-cyclopentyl-~Ltetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursors required , for the synthesis of 15 through 19 substituted prostaglandin analogs disclosed in Patent No. 1,033,727 are pxepared in the same way from the appropriate methyl esters.
Dimethyl 2-oxo-2-c~clodecy~eth~lphosphonate A solution of 20.4 g. (164 mmole~) dimethyl methyl-phosphonate ~Aldrich) in 200 ml. dry tetrahydro~uran is cool-ed to -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexane solution (Alfa Inorganics, Inc.) dropwise over a period of 20 minutes at such a rate that the reaction temperature never rises above -65. After an additional 5 minutes stirring at -78, 14.5 g. ~73.5 mmole) methyl cyclo-decane~arboxylate is added dropwise at a rate thak kept the r~action temperature leqs than -70 (20 minutes). After 1.0 , hour at -78 the reaction mixture is allowed to warm to ambient temperature, neutralized with 20 mlO acetic acid and rotary evaporated to a white gel. The gelatinous material is taken up in 50 ml. water, the aqueous pha~e extracted with 75 ml. portions of methylene chloride (4x), the combined organic , extracts are backwashed (75 ml. H2O), dried ~MgSO4), and con-`' centrated (water aspirator) to a crude residue and distilled to give dimethyl 2-oxo-2-cyclodecylethylpho~phonate.
The product of this Example is useful as the start-ing ma~erial for the synthesis of 15-cyclodecyl~-tetranor-prostaglandins of the A, E, or F series via the procedures disclosed in Patent No. 1,033,727. Other precursorq required for the synthe~is o~ 16 through 20 substikuted proskaglandin analogs disclosed in Patent No. 1,033,727 are prepared in the same way ~rom the appropriate methyl esters.
, , ~ . , .. ~ ,.
... . .
.
. . , : :
." ' ' ' ' :: ~ , s ~ . .
EX~MPLE 8 : Dimethyl 2-oxo-6-cyclopropylhexylpho~e_onate A solution o~ 20.4 g. (164 mmoles) dimethyl methyl-pho~phonate (~ldrich) in 200 ml. dry tetrahydro~uran is cool-S ed ~o -78 in a dry nitrogen atmosphere. To the stirred phosphonate solution is added 82.6 ml. of 2.25M n-butyl-lithium in hexan~ solution (Al~a Inorganics, Inc.) dropwiae over a period of 20 minute~ at such a rate that tha reaction ; tempera~ure never rises above -65. After an addltional 5 minu~es stirring at -78, 11.5 g. ~73.5 mmol~) methyl 5-cyclopropylvalerate i~ added dropwise at a rate that keep~
the react~on t~mperature le~s than -70~ (20 minutes)~ After 1.0 hour at -78 the reaction mixture i~ allowed to wa~m to a~bient temperature, neutralized with 20 ml. acetic acid and rotary evaporated ~o a white gel. The gelatinous material i8 taken up in 50 ml. water, the a~ueous phase extract~d with 75 ml. portion3 of methylene chlorid~ ~4x), thc combined organic extracts are backwashed (75 ml. H~O), dried ~MgSO4), and concentrated (water aspirator) to a crude re~ldue and distill~d to give dimethyl 2 oxo-6-cyclopropylhexylpho~phonate.
The product o~ this Example is uR~ful as the start-ing material for the synthesis of l9-cyclopropyl-~-tetranor-prostaglandins of the A, E or F erie~ via the procedures disclo~ed in Paten~ No. 1,033,727. Other precuxsor~ required for the synthesi3 o~ 15 thrsugh 18 and 20 ~ub3titute~ prosta-i glandin analogs disclo~ed in Patent Mo. 1,033,727 axa prepared in the same way from the appropriata methyl e~tex~.
.... :
~. 1 .~ .
;. ~ .
. . .
, . . . . , . , ... : ..
, . . . .
Claims (2)
1. A process for preparing a compound of the formula:
...II
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an integer from 0 to 5; which comprises reacting a lower alkyl ester of the formula:
wherein A and n are as defined above, with dimethyl methyl-phosphonate.
...II
wherein A is cycloalkyl of from three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2-(1,2,3,4-tetrahydronaphthyl), 2-indanyl or substituted 2-indanyl, wherein the substituent is halo, trifluoromethyl, lower alkyl or lower alkoxy; n is an integer from 0 to 5; which comprises reacting a lower alkyl ester of the formula:
wherein A and n are as defined above, with dimethyl methyl-phosphonate.
2. A compound of the formula:
...II
wherein A and n are as defined in claim 1, when prepared by a process according to claim 1.
...II
wherein A and n are as defined in claim 1, when prepared by a process according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA267,449A CA1052781A (en) | 1972-11-08 | 1976-12-08 | Prostaglandin analog precursors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30475072A | 1972-11-08 | 1972-11-08 | |
CA267,449A CA1052781A (en) | 1972-11-08 | 1976-12-08 | Prostaglandin analog precursors |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1052781A true CA1052781A (en) | 1979-04-17 |
Family
ID=25668408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA267,449A Expired CA1052781A (en) | 1972-11-08 | 1976-12-08 | Prostaglandin analog precursors |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1052781A (en) |
-
1976
- 1976-12-08 CA CA267,449A patent/CA1052781A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Trost et al. | New synthetic reactions. Convenient approach to methyl 3-oxo-4-pentenoate | |
EP0841063A1 (en) | Ketone derivatives and medicinal use thereof | |
IL50310A (en) | Dimethyl ketophosphonates | |
Yuan et al. | Enantioselective reduction of 2‐keto‐3‐haloalkane phosphonates by baker's yeast | |
Caldwell et al. | Synthesis of the lipophilic side chain of the cyclic hexadepsipeptide antibiotic L-156,602 | |
CA1052781A (en) | Prostaglandin analog precursors | |
EP0585104B1 (en) | A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor | |
US4323678A (en) | Process for the manufacture of diazinon | |
US3910958A (en) | Process for preparing arylacetic acids and esters thereof | |
CA1196000A (en) | Process for production of methyl 2- tetradecylglycidate | |
SU1068033A3 (en) | Process for preparing substituted trans-crysanthemates | |
CA1101874A (en) | Thiophene compounds | |
Durden et al. | Insecticidal thiophan-3-one O-(methylcarbamoyl) oximes | |
US3089896A (en) | Preparation of enolates of | |
Mikołajczyk et al. | α-Alkyl (aryl) sulfenyl substituted β-ketophosphonates: synthesis, properties and reactivity | |
JPH02292263A (en) | Production of 1-methyl-3-alkyl-5-pyrazole carboxylate | |
JPH0257535B2 (en) | ||
JPS5865249A (en) | Manufacture of dichloroacetic acid ester | |
Knol et al. | An alternative enantioselective synthesis of (+)-tricyclodecadienone | |
Gurskii et al. | Organoboron compounds: CDXCV. A regioselective reaction of hydride abstraction in the series of 3-alkyl-3-borabicyclo [4.3. 1] decane ate-complexes | |
US4808340A (en) | Process for preparing methyl 4-oxo-5-tetradecynoate | |
Petrova et al. | Stereoselectivity of the Wittig-Horner reaction with benzylphosphonate carbanions and aldehydes | |
HU176072B (en) | Process for producing 4-alpha-halogenomethyl-cyclopenta-square bracket-b-square bracket closed-furane derivatives | |
JPS6129351B2 (en) | ||
HU182691B (en) | Process for preparing 3-/2,2-dichloro-vinyl/-2,2-dimethyl-cyclopropane-carboxylic acid and esters thereof |